HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Raises Price Target to $21

Benzinga · 2d ago
HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $19 to $21.